NO313883B1 - Löselig fusjonsmolekyl og rekombinant fusjonsmolekyl som har bindingsspesifisitet for CD11a/CD18 - Google Patents

Löselig fusjonsmolekyl og rekombinant fusjonsmolekyl som har bindingsspesifisitet for CD11a/CD18 Download PDF

Info

Publication number
NO313883B1
NO313883B1 NO19942320A NO942320A NO313883B1 NO 313883 B1 NO313883 B1 NO 313883B1 NO 19942320 A NO19942320 A NO 19942320A NO 942320 A NO942320 A NO 942320A NO 313883 B1 NO313883 B1 NO 313883B1
Authority
NO
Norway
Prior art keywords
icam
cells
region
fusion molecule
tcr
Prior art date
Application number
NO19942320A
Other languages
English (en)
Norwegian (no)
Other versions
NO942320L (no
NO942320D0 (no
Inventor
Alejandro Aruffo
Nitin K Damle
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO942320L publication Critical patent/NO942320L/no
Publication of NO942320D0 publication Critical patent/NO942320D0/no
Publication of NO313883B1 publication Critical patent/NO313883B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70528—CD58
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/74—Inducing cell proliferation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/32—Fusion polypeptide fusions with soluble part of a cell surface receptor, "decoy receptors"

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NO19942320A 1991-12-20 1994-06-17 Löselig fusjonsmolekyl og rekombinant fusjonsmolekyl som har bindingsspesifisitet for CD11a/CD18 NO313883B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/811,129 US5861151A (en) 1991-12-20 1991-12-20 Soluble fusion molecules with binding specificity for cell adhesion molecules
PCT/US1992/010964 WO1993013210A1 (fr) 1991-12-20 1992-12-15 Proteines de fusion solubles a region constante d'immunoglobuline et a molecules d'adhesion intercellulaire (icam)

Publications (3)

Publication Number Publication Date
NO942320L NO942320L (no) 1994-06-17
NO942320D0 NO942320D0 (no) 1994-06-17
NO313883B1 true NO313883B1 (no) 2002-12-16

Family

ID=25205654

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19942320A NO313883B1 (no) 1991-12-20 1994-06-17 Löselig fusjonsmolekyl og rekombinant fusjonsmolekyl som har bindingsspesifisitet for CD11a/CD18

Country Status (21)

Country Link
US (1) US5861151A (fr)
EP (1) EP0619843B1 (fr)
JP (1) JP3414397B2 (fr)
KR (1) KR940703921A (fr)
AT (1) ATE190353T1 (fr)
AU (1) AU678144B2 (fr)
CA (1) CA2123303C (fr)
DE (1) DE69230762T2 (fr)
DK (1) DK0619843T3 (fr)
ES (1) ES2143499T3 (fr)
FI (1) FI113278B (fr)
GR (1) GR3033474T3 (fr)
IE (1) IE922926A1 (fr)
IL (1) IL104117A (fr)
MX (1) MX9207420A (fr)
NO (1) NO313883B1 (fr)
NZ (1) NZ245473A (fr)
PT (2) PT619843E (fr)
TW (1) TW246690B (fr)
WO (1) WO1993013210A1 (fr)
ZA (1) ZA929595B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2141076T3 (es) 1988-09-01 2000-03-16 Bayer Ag Proteina del receptor de rinovirus humano que inhibe la infectividad del virus.
US6130202A (en) * 1990-07-20 2000-10-10 Bayer Corporation Antiviral methods
US5932214A (en) * 1994-08-11 1999-08-03 Biogen, Inc. Treatment for inflammatory bowel disease with VLA-4 blockers
GB9914650D0 (en) * 1999-06-24 1999-08-25 Angyogene Pharmaceuticals Ltd Chimeric proteins mediating targeted apoptosis
AU6607100A (en) * 1999-07-23 2001-02-13 Regents Of The University Of California, The Anti-growth factor receptor avidin fusion proteins as universal vectors for drugdelivery
BRPI0209933B8 (pt) * 2001-05-24 2021-05-25 Zymogenetics Inc proteína de fusão, e, molécula de ácido nucleico
KR100453877B1 (ko) 2001-07-26 2004-10-20 메덱스젠 주식회사 연쇄체화에 의한 면역 글로블린 융합 단백질의 제조 방법 및 이 방법에 의해 제조된 ＴＮＦＲ/Ｆｃ 융합 단백질, 상기 단백질을 코딩하는 ＤＮＡ, 상기 ＤＮＡ를 포함하는벡터, 및 상기 벡터에 의한 형질전환체
US20050069549A1 (en) 2002-01-14 2005-03-31 William Herman Targeted ligands

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2201052T3 (es) * 1988-09-28 2004-03-16 Dana Farber Cancer Institute Moleculas de adhesion intercelular y sus ligandos de union.
ATE146222T1 (de) * 1989-03-09 1996-12-15 Blood Res Center Interzellulares adhäsions-molekül-2 und seine bindungsliganden

Also Published As

Publication number Publication date
JPH07502413A (ja) 1995-03-16
AU678144B2 (en) 1997-05-22
CA2123303C (fr) 2003-07-01
AU3327293A (en) 1993-07-28
PT619843E (pt) 2000-08-31
IL104117A (en) 1998-12-27
FI942943A0 (fi) 1994-06-17
WO1993013210A1 (fr) 1993-07-08
EP0619843B1 (fr) 2000-03-08
IE922926A1 (en) 1993-06-30
CA2123303A1 (fr) 1993-07-08
DK0619843T3 (da) 2000-06-05
NZ245473A (en) 1995-08-28
FI942943L (fi) 1994-06-17
PT101148A (pt) 1994-03-31
NO942320L (no) 1994-06-17
MX9207420A (es) 1993-06-01
GR3033474T3 (en) 2000-09-29
DE69230762T2 (de) 2000-07-13
JP3414397B2 (ja) 2003-06-09
FI113278B (fi) 2004-03-31
KR940703921A (ko) 1994-12-12
PT101148B (pt) 1999-08-31
ATE190353T1 (de) 2000-03-15
EP0619843A1 (fr) 1994-10-19
US5861151A (en) 1999-01-19
ZA929595B (en) 1993-08-19
IL104117A0 (en) 1993-05-13
DE69230762D1 (de) 2000-04-13
ES2143499T3 (es) 2000-05-16
NO942320D0 (no) 1994-06-17
TW246690B (fr) 1995-05-01

Similar Documents

Publication Publication Date Title
EP3166968B1 (fr) Compositions de récepteurs d'auto-anticorps chimériques et procédés afférents
US11390658B2 (en) Anti-CD7 chimeric antigen receptor and method of use thereof
US11643453B2 (en) Cell
NO316223B1 (no) Blanding omfattende et B7-bindende molekyl og et IL4-bindende molekyl, samtanvendelse derav
NO312465B1 (no) CTL4A reseptorprotein, DNA fusjonsproteiner og anvendelse derav samt in vitro fremgangsmåte, monoklonealt antistoff,kinesisk hamster-ovariecellelinje og farmasöytisk preparat
JP2021522790A (ja) ホスホリパーゼａ２受容体キメラ自己受容体ｔ細胞の組成物および方法
CN111542545A (zh) Cd38定向嵌合抗原受体构建体
US20230167184A1 (en) Bcma-specific antibody and chimeric antigen receptor
US20220211830A1 (en) Cell
NO313883B1 (no) Löselig fusjonsmolekyl og rekombinant fusjonsmolekyl som har bindingsspesifisitet for CD11a/CD18
EP4210733B1 (fr) Système d'expression inductible d'un adaptateur dans des cellules immunitaires
EP2167538A2 (fr) Identification de nouvelles isoformes du récepteur cd160 spécifique de cmh de classe i et ses utilisations
WO2022048621A1 (fr) Compositions et procédés permettant de cibler l'anticorps anti-rh
CN110678551A (zh) 经改造的t-细胞调节分子及其使用方法
EA050762B1 (ru) Аллогенные терапевтические клетки
Moingeon et al. Characterization of FcεRIγ in human natural killer cells
Harris et al. Engagement of CD45 during in vitro priming enhances antigen-specific Th cell frequencies
HK40030299A (en) Cd38-directed chimeric antigen receptor constructs